Baxter International Inc. (NYSE:BAX – Get Free Report) announced a quarterly dividend on Wednesday, October 28th. Stockholders of record on Friday, November 27th will be paid a dividend of $0.01 per share by the medical instruments supplier on Monday, January 4th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, November 27th.
Baxter International has decreased its dividend payment by an average of 0.1% annually over the last three years. Baxter International has a payout ratio of 1.5% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Baxter International to earn $2.00 per share next year, which means the company should continue to be able to cover its $0.04 annual dividend with an expected future payout ratio of 2.0%.
Baxter International Price Performance
BAX stock traded down $0.39 during mid-day trading on Friday, reaching $23.11. The company’s stock had a trading volume of 1,075,334 shares, compared to its average volume of 7,789,352. The stock has a market cap of $11.95 billion, a PE ratio of -11.16, a P/E/G ratio of 3.85 and a beta of 0.65. The company has a current ratio of 1.95, a quick ratio of 1.32 and a debt-to-equity ratio of 1.39. Baxter International has a fifty-two week low of $15.73 and a fifty-two week high of $30.00. The company’s 50 day moving average is $24.65 and its two-hundred day moving average is $21.35.
Baxter International (NYSE:BAX – Get Free Report) last released its quarterly earnings data on Thursday, October 29th. The medical instruments supplier reported $0.58 earnings per share for the quarter, topping analysts’ consensus estimates of $0.52 by $0.06. Baxter International had a positive return on equity of 16.57% and a negative net margin of 9.27%. The company had revenue of $2.98 billion for the quarter, compared to analyst estimates of $2.91 billion. During the same quarter in the previous year, the company posted $0.69 earnings per share. The firm’s revenue for the quarter was up 5.0% compared to the same quarter last year. Equities research analysts expect that Baxter International will post 2.04 EPS for the current year.
Baxter International News Roundup
Here are the key news stories impacting Baxter International this week:
- Positive Sentiment: Baxter reported third-quarter earnings of $0.58 per share, ahead of the $0.52 consensus estimate, while revenue increased 5% year over year to $2.98 billion and surpassed expectations. The company cited broad-based growth across its business. Baxter Q3 Earnings Beat on Broad-Based Growth, 2026 Outlook Raised
- Positive Sentiment: Management raised its full-year 2026 earnings outlook, signaling confidence in demand and the company’s operating performance. Baxter Raises 2026 Earnings Guidance
- Neutral Sentiment: Baxter declared a quarterly cash dividend of $0.01 per share, payable January 4 to shareholders of record November 27. The annualized yield is approximately 0.2%, making the payout a limited factor for income-focused investors. Baxter Third-Quarter Results and Dividend Announcement
- Negative Sentiment: Third-quarter EPS declined from $0.69 a year earlier to $0.58, and the company continues to face margin pressure. Its negative net margin adds to concerns about the quality and sustainability of earnings growth. Baxter Third-Quarter Earnings and Revenue Results
- Negative Sentiment: Baxter received an FDA warning letter concerning current Good Manufacturing Practice violations. The regulatory action raises potential compliance, remediation, cost and operational risks for investors. Baxter Received FDA Warning Letter Over CGMP Violations
About Baxter International
Baxter International Inc is a global medical products and healthcare technology company headquartered in Deerfield, Illinois. The company develops, manufactures and distributes products used in hospitals, clinics, ambulatory care centers and other healthcare settings.
Baxter’s portfolio has included intravenous therapies and administration systems, infusion pumps, connected-care technologies, surgical products, patient monitoring equipment and products used in medication preparation and delivery.
Featured Articles
- Five stocks we like better than Baxter International
- Advanced Micro Devices’ Meta Platforms Partnership Goes Beyond a $1 Billion Investment
- Chipotle’s $32 Floor: Is a Major Stock Rebound Coming?
- SaaS-Pocalypse II: Is ServiceNow’s Sell-Off Another Buying Opportunity?
- Robinhood Stock Is Down Nearly 37%—So Why Is Wall Street Still So Bullish?
Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.
